AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

February 11, 2025 Latest News Australian Biotech BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Australian clinical-stage radiopharmaceutical company AdvanCell has announced an expansion of its strategic collaboration with Eli Lilly to research and develop innovative cancer treatments. …

Subscribe now to continue reading.

Latest Video

Historical change on pharmacy prescribing could be a sign of more to come
February 10, 2025 - Latest News
Victorian official appointed to HTA Review implementation advisory group
February 10, 2025 - Latest News
'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'
February 10, 2025 - Latest News
Proponents of meaningful reform might consider pharmacy prescribing as a case study
February 11, 2025 - Latest News
Sigma upgrades guidance as it prepares for Chemist Warehouse merger
February 10, 2025 - Latest News

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

This is a preview of subscriber content

Latest Video

Most Read

Historical change on pharmacy prescribing could be a sign of more to come

Victorian official appointed to HTA Review implementation advisory group

'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'

Proponents of meaningful reform might consider pharmacy prescribing as a case study

Sigma upgrades guidance as it prepares for Chemist Warehouse merger

New Stories

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Rare Cancers Australia says election is the chance to end the ‘cancer lottery’

Specialised Therapeutics announces Thai approval of breast cancer therapy

Merck adds experienced industry executive to leadership team

Sandoz summit promotes reform to boost the use of biosimilars

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Sign In

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

This is a preview of subscriber content

Latest Video

Most Read

Historical change on pharmacy prescribing could be a sign of more to come

Victorian official appointed to HTA Review implementation advisory group

'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'

Proponents of meaningful reform might consider pharmacy prescribing as a case study

Sigma upgrades guidance as it prepares for Chemist Warehouse merger

Follow Us

New Stories

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus

Rare Cancers Australia says election is the chance to end the ‘cancer lottery’

Specialised Therapeutics announces Thai approval of breast cancer therapy

Merck adds experienced industry executive to leadership team

Sandoz summit promotes reform to boost the use of biosimilars

AdvanCell extends collaboration with Lilly to advance novel targeted alpha therapies

Immunoglobulin sales drives a strong first half for CSL but lower immunisation rates hit Seqirus